Elections

How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

ASTRO’s Strategic Plan serves an important purpose for our professional society in establishing pragmatic goals for its members. To me, its goals are a clear call to action during this challenging period when traditional reimbursement systems are undergoing profound change. Looking forward, radiation oncology and other fields of medicine will be held increasingly to account for the value of their services to the well-being of the patient.

The Strategic Plan and its stated Health Policy goals focus and inspire me to think about how we as radiation oncologists can promote our services compellingly and convincingly. It’s not enough to know the great value of our care for the cancer patient and expect that others who govern our payments see it as clearly as we do. In the next few years, there will be a growing competition among different types of cancer care providers that may also include various industry groups, all of whom will be making an argument for fair reimbursement for their services and products. Health Policy plays a crucial role in this scenario, preparing information that supports our cause and helping to organize an effective advocacy through which that information may be transmitted to key policy and decision makers in government and within key private entities.

As I look at the current state of radiation oncology, I am very encouraged for our future. We are lucky to have inherited this field of medicine from our predecessors, who wisely navigated us through previous transitions in payment method and have placed us in a good position to plan for the years ahead. We continue to attract smart and talented people into our field in excess proportion to our small numbers. Further, we have a broad representation of background and experience at multiple levels through the organization and a cooperative spirit among our many groups. We will need all these advantages in the near future, and the Strategic Plan’s goals provide us the direction and momentum with which we can apply them to our patients’ benefit and ours.

EDUCATION

• MD, University of Chicago, 1995

POSTGRADUATE EDUCATION

• Residency, Radiation Oncology, University of Chicago, 1996-2000
• Internship, General Surgery, Hennepin County Medical Center, Minneapolis, 1995-1996

SERVICE TO ASTRO

• Board of Directors, 2019-2023 
• Chair, Heath Policy Council, 2021-2023
• Co-Chair, Health Policy Council, 2019-2021
• Chair, Rural Task Force Supervision Workgroup, 2019 
• Ex Officio, Payer Relations Subcommittee, 2018 – present
• Ex Officio, Code Utilization and Application Subcommittee, 2018 – present
• Ex Officio, Code Development and Valuation Subcommittee, 2018 – present
• Member, Coding and Coverage Seminar, 2017 – present 
• Member, Payment Reform Workgroup, 2014-2018
• Member, Health Policy Committee, 2014-2017
• Member, Code Utilization and Application Subcommittee, 2014-2018
• Chair, Payer Relations Subcommittee, 2015-2017
• Member, Practice Accreditation Committee, 2013-2016
• Member, Health Information Technology Subcommittee, 2010-2016
• Vice-chair, Payer Relations Subcommittee, 2014-2015
• Chair, Practice Accreditation Appeals Committee, 2014-2015
• Member, Payer Relations Subcommittee, 2013-2014
• Member, Practice Accreditation Workgroup, 2012-2013
• Member, Regulatory Subcommittee, 2011-2013

SERVICE TO OTHER ONCOLOGY AND RADIOLOGY ORGANIZATIONS

• Member, American Board of Radiology GU Committee, 2016-2023
• Board of Directors, The Radiosurgery Society, 2013-2016 

BIOGRAPHICAL SKETCH

After completing residency, I had no ambition other than to be a community physician practicing good medicine. I entered private practice in 2000 and joined a large radiation oncology group in Florida. Since then, the practice has grown into a much larger multi-specialty oncology services company, and I gradually involved myself more in its management. I have taken on administrative projects related to payer contracting, revenue cycle management, business intelligence and compliance and am fortunate to have been mentored by smart people in each of these functions that are critical to the business of medicine. One specific project worth mentioning is my company’s design and execution of a bundled payment model for radiation oncology in 2012, which was a first between a provider and a major commercial insurer. That agreement remains active today and provides a basis for the Radiation Oncology Case Rate model, a legislative proposal recently introduced in the U.S. Senate to stabilize our Medicare payments against declining fractionation.

Over time, it became clear to me that ASTRO’s Health Policy committees were addressing many of the same problems – improper claims denials, incorrect coding, out-of-date coverage policies – that I needed to solve within my administrative capacity for my company. I first joined the Payer Relation Committee and was impressed with the seriousness and efficiency with which the group worked in managing coverage problems related to Medicare and private insurance policies. I have since worked on all other Health Policy committees and eventually served as Health Policy Chair.

How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

Radiation Oncology: A Legacy of Leadership, a Vision for the Future
Historically, therapeutic radiation existed in the shadow of diagnostic radiology — a small subcommittee within a larger field. Over time radiation oncology emerged as an essential pillar of modern cancer care. We are pioneers in data-driven oncology and are defined by precision, compassion, and innovation — committed to improving lives through evidence-based, technologically advanced, equitable care. 

Defining Our Value
Consider this; treating every Medicare patient with radiation therapy for a full year costs less than a single drug used by only 14% of those patients. Yet, our value is often underestimated. Each year, we cure more cancers with fewer complications — delivering safe, effective care. Our value should not be measured in comparison to or confined by outdated metrics. It should reflect the unique combination of outcomes, affordability and humanity we bring to oncology.

Our strategic plan outlines the goal to remain not only an equal partner in oncologic care, but to continue as leaders in innovation, value, equality and comprehensive patient care.

Elevating Our Voice and Visibility
ASTRO’s strategy to elevate the national visibility of Radiation Oncology is timely and essential. As president, I would deepen collaboration with sister societies and expand our presence in the broader oncologic community. We must champion our specialty through tumor boards, joint publications and multidisciplinary conferences. By welcoming contributions from other fields to our journals, podcasts and scientific meetings, we foster collaboration and promote a deeper understanding of our unique value.

We must continue to recruit and support a diverse, talented workforce, fostering mentorship and strong engagement with students and residents.

Innovation Beyond Technology
While we continue to lead in technological advancements, the next frontier lies beyond hardware. ASTRO members are pioneering research into tumor biology and radiation sensitivity — discoveries that could transform our field just as molecular science revolutionized systemic therapies. Innovation must also focus on safety, efficiency and measurable outcomes.

We are also rapidly expanding our understanding of radiation as a safe and effective modality for treating benign conditions that may impact quality of life. Our goal is to responsibly expand the role of radiation across a broader spectrum of diseases.

Policy, Advocacy and the Path Forward
I am deeply committed to health policy. ASTRO must continue to advocate for value-based care models that reward quality, not quantity. We must protect evidence-based guidelines, resist unnecessary administrative burdens, and oppose policies that stifle innovation or create unfair competition. ASTRO’s leadership in these areas will empower our members to thrive in a changing health care landscape.

Patient-centered, Outcome-driven Care
As health care evolves to prioritize outcomes and patient satisfaction, our mission remains clear: improve tumor control while reducing toxicity. We must support research, clinical pathways, and decision-making tools that enhance care quality and equity.

Through continued innovation and advocacy, we can ensure radiation oncology remains a leader in delivering informed, compassionate and life-changing care, and I feel as President I am prepared to lead the society and fulfill our strategic goals.

EDUCATION

• MD, Northwestern University (AOA), Chicago, 1991
• BA, Biology (Summa Cum Laude), Vanderbilt University, Nashville, Tennessee, 1986

POSTGRADUATE EDUCATION

• Health Leadership Academy/AAMC Leadership Academy mini-MBA certificate, San Diego and Washington, DC, 2021-2022
• Health Economics Fellowship, ASTRO
• Resident, Radiation Oncology, University of Louisville, Louisville, Kentucky, 1998-2001
• Fellowship, Gynecologic Oncology, University of Louisville, Louisville, Kentucky, 1996-1998
• Resident, Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan, 1991-1995

ACADEMIC APPOINTMENTS

• Associate Dean, University of San Diego Health (UCSD), San Diego, 2024 – present
• Professor, Radiation Medicine and Applied Sciences, University of California San Diego, 2015 – present

HOSPITAL APPOINTMENTS

• Chief Medical Officer, UCSD Health, San Diego, 2024 – present
• Department of Radiation Medicine, UCSD, San Diego, 2006 – present

SERVICE TO ASTRO

• Board of Directors, Health Polcy Council Chair and Vice-chair, 2021 – present
• Chair, Health Policy Committee, 2019-2021
• CPT alternate, 2018 – present
• Member, CDVC, 2015 – present
• Member, CUAC Committee, 2017 – present
• Senior Editor, Gynecology
  • International Journal of Radiation Oncology Biology Physics, 2009-2010
  • Advances
  • Practical Radiation Oncology, 2020 – present
• Search Committee
  • Advances
  • Practical Radiation Oncology
  • International Journal of Radiation Oncology Biology Physics, 2020
• Member, Emerging Technology Committee, 2012-2015
• Reviewer ASTRO Annual Meeting abstracts: Breast, Gyn, 2013-2017, 2019, 2021-2025

SERVICE TO OTHER ONCOLOGY OR RADIOLOGY ORGANIZATIONS

• NCCN
  • Vice Chair, Cervical Uterine Panel, 2018 – present
  • Panel member, 2013 – present
• American Board of Radiology
  • Trustee, 2020 – present
  • Oral Boards Chair, Gynecology, 2019-2020
  • Oral and written boards committee member, 2004-2019
• American Radium Society
  • Appropriateness Criteria, Gynecology, 2017 – present
• American Brachytherapy Society
  • Chairwoman of the Board, 2018-2019
  • President, 2017-2018
  • Vice President, 2016-2017
  • Secretary, 2014-2016
• ASCO
  • Guideline Advisory Group
  • Committee on Economics
  • Committee on Coding and Nomenclature
• Kukuna O Ka La
  • President
  • Chairwoman
• ACRO
  • Board Member
• American College of Radiology
  • Appropriateness Criteria, Gynecology, 2009-2017
  • Panel on Radiation Oncology/Gynecology, 2011-2017

How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

As a long-time ASTRO member and current Chair of the Health Policy Committee, I recognize that ASTRO’s Strategic Plan aligns with several important aspects of my professional values and leadership interests. Its focus on advocacy, quality care, education and continuous innovation addresses significant and evolving needs within radiation oncology and provides a structured framework to guide the specialty’s ongoing development.

Throughout my more than a decade of involvement in ASTRO’s health policy structure — including leadership roles as Vice-chair of the Health Policy and Code Development and Valuation Subcommittees — I have observed the critical role that thoughtful and strategic advocacy plays in shaping access, reimbursement and equity in cancer care. These experiences have underscored the challenges radiation oncologists face in navigating complex payer systems and regulatory environments. If elected as a Board Member, I would prioritize supporting initiatives that empower radiation oncologists to make clinical decisions grounded in evidence, while advocating for reimbursement models that are both fair and sustainable for various practice settings, including independent clinics and academic institutions.

ASTRO’s strategic plan’s emphasis on promoting high-quality, equitable care is consistent with my professional focus, particularly through my work in pediatric oncology, proton therapy, and leadership in national guideline development. Over the years, I have aimed to prioritize outcomes-focused care and to address access to care that can affect patient populations. I believe that these experiences equip me to contribute meaningfully to ASTRO’s quality initiatives and the development of clinical guidance that improves patient outcomes across the board.

In addition, ASTRO’s commitment to education, mentorship and research aligns closely with my ongoing efforts as an ABR examiner, educator and clinical investigator. I am dedicated to supporting lifelong learning opportunities and fostering research that advances the evidence base and demonstrates the value of radiation oncology in modern cancer treatment.

ASTRO’s Strategic Plan provides a thoughtful direction for the future of radiation oncology. I would view it as an important responsibility to bring my experience, insights and measured judgment to the Board, contributing to the successful implementation of the plan’s objectives in a way that benefits both the specialty and the patients we serve.

EDUCATION

• MD, McGill University, Montreal, Quebec, Canada, 1992
• BSc, Biochemistry (Hons), University of Toronto, Toronto, Canada, 1988

POSTGRADUATE EDUCATION

• Fellowship, Proton Therapy, Massachusetts General Hospital, Boston, 1996-1997
• Resident, Radiation Oncology, McGill University, Montreal, Quebec, Canada, 1993-1996
• Internship, Internal Medicine, McGill University, Montreal, Quebec, Canada, 1992-1993

ACADEMIC APPOINTMENTS

• Professor, Radiation Oncology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, 2017 – present
• Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 2010-2017
• Associate Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 2005-2010
• Assistant Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 2002-2005
• Assistant Professor, Radiation Oncology, New England Medical Center, Tufts University, Boston, 1998-2002
• Instructor, Radiation Oncology, New England Medical Center, Tufts University, Boston, 1997-1998

HOSPITAL APPOINTMENTS 

• Consultant (Joint Appointment) - Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, 2024 – present
• Consultant - Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, 2018 –present
• Medical Director of Particle Therapy, Mayo Clinic, Rochester, Minnesota, 2018 – present
• Senior Associate Consultant, Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, 2017-2018
• Department of Radiation Oncology, MD Anderson Cancer Center, Houston, 2002-2017
• Department or Radiation Oncology, New England Medical Center, Boston, 1997-2002

SERVICE TO ASTRO

• Chair, Health Policy Committee, 2024 – present
• Vice-chair, Health Policy Committee, 2023-2024
• Vice-chair, Code Development and Valuation Subcommittee, 2021 – present
• Member, Payer Relations Subcommittee, 2021 – present
• Member, Code Development and Valuation Subcommittee, 2020-2021
• Member, Health Policy Committee, 2020-2023
• Vice-chair, Payer Relations Subcommittee, 2019-2021
• Member, Payer Relations Subcommittee, 2013-2019
• Member, Annual Meeting Track Pediatrics, 2013-2015, 2017-2020
• Member, Annual Meeting Scientific Committee, 2012-2015

SERVICE TO OTHER ONCOLOGY OR RADIOLOGY ORGANIZATIONS 

• International Commission for Radiation Unites and Measurements
  • Co-chair for ICRU Committee Report Prescribing, Recording, and Reporting Proton-Beam Therapy, 2021 – present
• NCI Brain Malignancies Steering Committee
  • Co-chair, 2024 – present
  • Member, 2020-2024
• National Comprehensive Cancer Network
  • Vice-chair, Pediatric Brain Tumors, 2022 – present
• Particle Therapy Cooperative Oncology Group
  • Vice-chair, 2022 – present
  • Scientific Program Committee Co-chair 
• Particle Therapy Cooperative Group - North America 
  • President 2020-2024
  • Secretary 2014-2019
• American Board of Radiology
  • Examiner 2022 – present
  • Content writer 2018 – present
• Pediatric Radiation Oncology Society
  • Executive committee member: 2015 – present
• American College of Radiology 
  • Site Surveyor 2014-2017
• Commission on Accreditation of Medical Physics Education Programs
  • Site Reviewer, 2013-2017

How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

As an active and long-standing member of ASTRO with an extensive history of service to Science Council, I am committed to advancing our field of radiation oncology. My experience in various leadership roles within ASTRO has equipped me with an understanding of the values and goals of our organization and its membership. As Vice-chair of Science Council and a Board Member of ASTRO, I would strongly advocate for the prioritization of clinical, translational and basic science within our society while maintaining focus on patient-centered clinical care.

Leadership Inspired by Strategic Goals

ASTRO’s mission to advance high-quality patient care, support research and drive policy advocacy resonates with my vision for the future of ASTRO. The strategic plan’s emphasis on inclusivity aligns with my belief that a diverse leadership team enhances innovation and decision making. Leaders who promote a welcoming culture are essential to growing an engaged membership and advancing our mission.

Key Characteristics of a Science Council Vice-chair and ASTRO Board Member:

1.    Engagement and Collaboration: Engaging early career clinicians and scientists and fostering collaboration within our community are essential for the growth and continued relevancy of ASTRO as the largest radiation oncology community in the world. Collaborative and consensus-building leaders will enhance partnerships that advance the field and improve outcomes for our patients. As Vice-chair, I will ensure that voices from all corners of the society – including clinicians, researchers, medical physicists and biologists – are heard and empowered. Efforts to explicitly include early career members are particularly important for the health and longevity of our society.
2.    Clinical Innovation and Research Advocacy: Promoting innovation and expanding funding opportunities are critical for our future. Having served Science Council for over a decade, I have developed an appreciation for leaders who are committed to fostering a vibrant research community that will ensure radiation therapy continues to evolve and progress. Whether disruptive research that creates new opportunities for the use of radiation to treat human disease or technological advances focused on improving existing approaches, the health of our society is linked to our ability to innovate as a field for the benefit of our patients.
3.    Patient-centered Care and Policy Advocacy: Effective leaders must advocate for policy that supports the role of radiation oncology in the health care system. They must be credible expert clinicians who can educate policymakers on the benefits and value of radiation therapy. Leaders who can influence policy to expand access and ensure treatment decisions are based on clinical evidence will be pivotal in advancing high-quality patient-centered care and promoting quality and safety in all environments.
4.    Educational Excellence: Ensuring access to innovative education is essential for maintaining high standards of care in radiation oncology. Leaders who actively promote adapting educational content to evolving trends and practice needs will support the professional development of clinicians throughout their careers.

My vision as Vice-chair of Science Council is to promote and lead a scientific agenda that is as dynamic and diverse as our membership and the communities we serve. Through strategic advocacy, inclusive engagement and a relentless focus on impact, I am committed to helping ASTRO shape a future where scientific research drives innovation and excellence in clinical care to ultimately improve patient outcomes.

EDUCATION

• PhD, Medical Physics, Purdue University, West Lafayette, Indiana, 2006
• BA, Physics, Middlebury College, Middlebury, Vermont, 2002

POSTGRADUATE EDUCATION

• Resident, Radiation Oncology Physics, Stanford University, Stanford, California, 2006-2008
• Internship, Radiation Oncology Physics, Medical College of Wisconsin, Milwaukee, 2004

ACADEMIC APPOINTMENTS

• Professor and Vice Chair, Therapeutic Radiology, Yale University, New Haven, Connecticut, 2022 – present
• Associate Professor, Radiation Oncology, University of Pennsylvania, Philadelphia, 2019-2022
• Associate Professor, Therapeutic Radiology, Yale University, New Haven, Connecticut, 2014-2019
• Assistant Professor, Therapeutic Radiology, Yale University, New Haven, Connecticut, 2008-2014

Hospital Appointments

• Director of Medical Physics, Radiation Oncology, Yale New Haven Hospital, New Haven, Connecticut, 2022 – present
• Chair, Radiation Safety Committee, Yale New Haven Hospital, New Haven, Connecticut, 2022 –present
• Director of Clinical Operations, Physics Division, Department of Radiation Oncology, University of Pennsylvania, Philadelphia, 2019-2022
• Medical Physicist, Radiation Oncology, Yale New Haven Hospital, New Haven, Connecticut, 2008-2019

SERVICE TO ASTRO

• Past Chair, Science Education and Program Development Committee, 2022-2024
• Member, Scientific Review Panel, 2023 – present
• Member, Annual Meeting Track – Physics, 2013-2014, 2017-2019, 2023 – present
• Member, ASTRO Career Mentor Program, 2022 – present
• Chair, Science Education and Program Development Committee, 2020-2022
• Vice-chair, Science Education and Program Development Committee, 2018-2020
• Member, Science Education and Program Development Committee, 2013-2024
• Member, Annual Meeting Steering Committee, 2020-2023
• Member, Science Council Steering Committee, 2018-2023
• Member, Annual Meeting Education Committee, 2018-2023
• Member, Promoting Science through Research and Training Committee, 2017-2022
• Member, Clinical, Translational, and Basic Science Advisory Subcommittee, 2016-2017
• Member, Radiation and Cancer Biology Committee, 2013-2014

SERVICE TO OTHER ONCOLOGY OR RADIOLOGY ORGANIZATIONS

• International Journal of Radiation Oncology, Biology, and Physics
  • Deputy Editor and Section, Physics, 2024 – present
  • Executive Editor and Section Editor, Physics, 2021-2024
  • Senior Editor, Physics, 2019-2021
  • Associate Senior Editor, Physics, 2016-2019
• American Board of Radiology
  • Chair, Medical Physics Clinical Exam Committee, 2024 – present
  • Associate Chair, Medical Physics Clinical Exam Committee, 2023
  • Member, Medical Physics Test Assembly, 2023 – present
  • Member, Medical Physics Clinical Exam Committee, 2018 – present
• American Association of Physicists in Medicine
  • Member, Particle Therapy Subcommittee, 2024 – present
  • Member, Work Group on Particle Beams, 2021-2024
  • Member, Molecular Imaging in Radiation Oncology Work Group, 2018-2024
  • Program Director, Therapy Education for the Annual Meeting of the AAPM, 2020
  • Program Co-Director, Therapy Education for the Annual Meeting of the AAPM, 2019
  • Member, Annual Meeting Education Program Working Group, 2018-2020
  • Member, Audit Committee, 2018-2019
  • Member, Board of Directors, 2015-2017
  • Member, Regional Organization Committee, 2015-2017
  • Member, Task Group No. 256 on Proton Relative Biological Effectiveness, 2013-2016
  • Member, Professional Development Needs Assessment Subcommittee, 2012-2014
  • Member, International Educational Activities Committee, 2012-2014
  • Member, International Affairs Committee, Member, 2011-2014
  • Vice-Chair/Member, African Affairs Subcommittee, 2007-2016
  • Chapter Representative/Past-President/President/President-Elect, Connecticut Area Medical Physics Society chapter of AAPM, President-Elect 2011-2017
  • Past-President/President/President-Elect, N. California Chapter of AAPM, 2007-2009

BIOGRAPHICAL SKETCH

Dr. David J. Carlson has been an active member of ASTRO since graduate school. He currently serves as Professor, Vice Chair, and Director of Medical Physics in the Department of Radiation Oncology at the Yale University School of Medicine and Yale-New Haven Health. Dr. Carlson received his Bachelor’s degree in Physics from Middlebury College and his PhD in Medical Physics from Purdue University. He completed his residency in Radiation Oncology Physics at Stanford University. After residency, he was a member of the Medical Physics faculty at Yale for over a decade before joining the faculty at the University of Pennsylvania where he served as an Associate Professor and the Director of Physics Operations in the Department of Radiation Oncology. Dr. Carlson’s clinical and research interests include the clinical implementation of novel technology and translational multi-disciplinary collaborations with physicians and biologists. The goals of his research are to improve treatment outcomes for cancer patients undergoing radiation therapy by developing accurate models of treatment response and advancing our understanding of the underlying biophysical mechanisms that govern radiation response. Dr. Carlson currently serves as Executive Editor and Section Editor for Physics for the International Journal of Radiation Oncology, Biology, and Physics, is a Fellow and past Member of the Board of Directors of the American Association of Physicists in Medicine (AAPM), and is Past Chair of the Science Education and Program Development committee of the American Society for Radiation Oncology (ASTRO). He was elected as a Fellow of ASTRO in 2023.

How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

ASTRO's vision of "improving the lives of people with cancer with radiation therapy" deeply resonates with my career-long commitment to advancing radiation oncology through scientific innovation and quality assurance. As Science Council Vice-chair, I would leverage my extensive experience in clinical trials, quality assurance, and emerging technologies to fulfill ASTRO's mission of promoting equitable, high-quality care.

Driving High-Quality Care through Scientific Excellence
My leadership of the IROC Philadelphia QA Center and role as Chair of NRG Oncology's Medical Physics Subcommittee have provided unique insights into ensuring treatment quality across diverse practice settings. I would prioritize initiatives that translate scientific advances into tangible improvements in patient care, focusing on developing evidence-based guidelines and quality metrics that are both rigorous and practical for implementation across all practice environments.

Fostering Innovation and Technology Integration
With hundreds of peer-reviewed publications spanning IMRT optimization, AI applications, and radiomics, I understand the transformative potential of emerging technologies. As Vice-chair, I would champion responsible innovation that enhances treatment precision while ensuring accessibility. This includes supporting research into AI-driven treatment planning, advanced imaging integration, and novel therapeutic approaches, such as FLASH and radiopharmaceutical therapies, with a focus on reducing disparities in access to advanced treatments.

Building an Inclusive Scientific Community
Having mentored numerous residents and junior faculty throughout my career, I recognize that diversity in our workforce drives innovation. I would work to create pathways for early-career practitioners and underrepresented groups to engage in radiation oncology research, ensuring our scientific endeavors reflect and serve our diverse patient populations. This includes expanding mentorship programs, creating accessible research funding opportunities, and fostering collaborative networks that break down institutional barriers.

Advancing Data Science and Standardization
My work with AAPM TG-263 and O3 on standardization and leadership in IROC and NRG's bioinformatics-related positions positions me to address critical challenges in data harmonization. I would advocate for standardized data collection and sharing protocols that enable large-scale outcomes research while protecting patient privacy. This infrastructure is crucial for realizing the promise of precision medicine and ensuring that insights from clinical trials are rapidly translated into community practice.

Strengthening Education and Knowledge Dissemination
Education is fundamental to advancing our field. I would support innovative educational initiatives that bridge the gap between cutting-edge research and clinical practice, ensuring all radiation oncology professionals have access to the latest scientific developments. This includes expanding virtual learning opportunities, developing competency-based curricula, and creating resources that support continuous professional development throughout one's career.

Commitment to Collaboration
My experience across academic, clinical trial, and professional society leadership has taught me that our most significant advances come through collaboration. As Science Council Vice-chair, I would foster partnerships among ASTRO, other professional societies, industry partners, and patient advocacy groups to accelerate scientific progress and ensure that innovations serve the needs of patients.

I am committed to ensuring that ASTRO's Science Council remains a driving force for innovation, quality, and equity in radiation oncology, always keeping our ultimate goal in focus: improving the lives of cancer patients through excellent science and compassionate care.

EDUCATION

• PhD, Physics, Temple University School of Arts & Sciences, 1996 
• MS, Physics, Temple University School of Arts & Sciences, 1992 
• BS, Optical Engineering, Tsinghua University School of Engineering, 1989

POSTGRADUATE EDUCATION

• Post-Doctoral Fellow, Medical Physics, Radiation Oncology, University of Pennsylvania, 1996-1998

ACADEMIC APPOINTMENTS

• Professor, Department of Radiation Oncology, University of Pennsylvania, 2015 – present 
• Professor, Department of Radiation Oncology, Jefferson Medical College, 2012-2015 
• Associate Professor, Department of Radiation Oncology, Jefferson Medical College, 2006-2012 
• Assistant Professor, Department of Radiation Oncology, Jefferson Medical College, 1999-2006

HOSPITAL APPOINTMENTS

• Director of Clinical Physics Research and Informatics, Radiation Oncology, Hospital of the University of Pennsylvania, 2015 – present 
• Clinical Director, Medical Physics Division, Radiation Oncology, Thomas Jefferson University Hospital, 2006-2011

SERVICE TO ASTRO

• Member, ASTRO Fellow Class 2024 
• Co-Chair (2016-2018, 2023 – present) and Member (2013 – present), Science Council Steering Committee 
• Chair, Scientific Education and Program Development Committee, 2013-2016 
• Chair, Physics Core Curriculum Subcommittee, Research Council, 2009-2015 
• Member, Scientific Education and Program Development Committee, 2008-2015

SERVICE TO OTHER ONCOLOGY OR RADIOLOGY ORGANIZATIONS

• American Association of Physicists in Medicine (AAPM)
  • Fellow, 2012 – present 
  • Chair, Big Data subcommittee, 2025 – present
  • Vice-chair, WG on Integrated Clinical Evidence Generation for Reirradiation, 2025 –present
  • Member, Science Council, 2025 – present
  • Vice-chair, SC263 - Standardized Categorizations and Nomenclatures Supporting Clinical and Research Efforts in Radiation Oncology Subcommittee, 2020 – present
  • Member, Big Data Subcommittee, Science Council, 2019 – present
  • Chair, Radiation Oncology Medical Physics Education Subcommittee, 2011-2017
  • Chair, Task Group on IMRT QA, 2005-2009
• NCI Clinical Trials Network
  • Chair, Medical Physics Subcommittee, Center for Innovation in Radiation Oncology, NRG Oncology, 2013 – present
  • Director, IROC Philadelphia RT, 2013 – present
• NCI Division of Cancer Treatment and Diagnosis
  • Co-Chair, Radiopharmaceutical Dosimetry Interest Group, 2017-2024
  • Co-Chair, Quantitative Imaging in Radiotherapy Interest Group, 2017 – present

BIOGRAPHICAL SKETCH

Dr. Ying Xiao is a Professor of Radiation Oncology at the University of Pennsylvania. A Fellow of both the American Association of Physicists in Medicine (AAPM, 2015) and the American Society for Radiation Oncology (ASTRO, 2024), Dr. Xiao has established herself as a leading figure in radiation oncology quality assurance and clinical trials.

With a PhD in Physics from Temple University (1996) and postdoctoral training at the University of Pennsylvania, Dr. Xiao has dedicated her career to advancing radiation therapy through rigorous quality standards and innovative technologies. She holds pivotal national leadership positions, including Director of the IROC Philadelphia QA Center, supporting NCI multi-center clinical trials, and Chair of the Medical Physics Subcommittee for the Center of Innovation in Radiation Oncology (CIRO) of NRG Oncology.

Dr. Xiao's research focuses on radiation oncology quality assurance, big data analytics, artificial intelligence applications and radiomics. She has authored hundreds of peer-reviewed publications and contributed to numerous book chapters, establishing her as a thought leader in standardizing radiotherapy data elements and ensuring quality in clinical trials. Her participation in AAPM Task Group 263 and O3 has been instrumental in standardization in radiation oncology.

Throughout her career, Dr. Xiao has secured substantial research funding from the NIH/NCI and other sources, demonstrating her commitment to enhancing cancer treatment outcomes. She actively mentors the next generation of medical physicists. She contributes to international collaborations, advancing the field of radiation oncology globally through her expertise in quality assurance, clinical trial design and emerging technologies.

How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

As a radiation oncologist, educator and clinical leader, with a background in research, multidisciplinary care and innovation, my professional goals and values align closely with ASTRO’s Strategic Plan. If selected for the role of Secretary/Treasurer, I would bring a strong commitment to advancing ASTRO’s priorities, particularly in improving access to advanced care, promoting scientific innovation and supporting sound health policy.

ASTRO’s mission to promote high-quality care reflects much of my work across both academic and community settings. As Medical Director of Radiation Oncology for WellSpan Health in York, Pennsylvania, a regional health system with five cancer centers, I’ve helped lead efforts to standardize protocols and bring cutting-edge therapies closer to home. These include liver-directed therapies, radiopharmaceuticals and proton therapy through strategic partnerships with Johns Hopkins and the Maryland Proton Treatment Center. These efforts have expanded community access to treatments once limited to major academic centers, helping to ensure that geography is not a barrier to high-quality cancer care.

Supporting the next generation of oncologists is also a personal and professional priority. My path from basic science into clinical practice has given me a broad perspective on mentorship and career development. I’ve worked closely with medical students, residents and fellows to foster learning and leadership, particularly in community-based settings where exposure to advanced techniques can be limited. Creating collaborative, multidisciplinary environments that extend beyond traditional academic borders has been a central part of this work.

In addition to my clinical and teaching responsibilities, I’ve served on several ASTRO committees, including those focused on finance, health policy, payer relations and community engagement. These experiences have helped me understand the practical impact of national policy decisions on radiation oncology practices of all sizes. ASTRO’s role in advocating for clinical autonomy, appropriate reimbursement and broader access to care is one I strongly support.

To complement this background, I am pursuing an MBA at Boston University. The training has strengthened my understanding of financial strategy, healthcare operations, and long-term organizational planning. These tools will directly inform my approach to the Secretary/Treasurer role, where careful financial oversight and forward-thinking stewardship are essential.

ASTRO’s dedication to professional education and patient awareness also resonates with my work in national guideline development, oral board examinations, and clinical practice standardization. I believe it’s essential that radiation therapy be not only accessible, but also well-understood by patients, referring physicians, and the broader medical community.

ASTRO’s Strategic Plan is a vision that reflects the future of our field. I would be honored to serve as Secretary/Treasurer and contribute to that future by helping ASTRO expand access to advanced care, support innovation and remain a strong voice for all corners of our profession.

EDUCATION 

• MBA, Boston University, Boston, 2026 (anticipated)
• DO, Kansas City University of Medicine, Kansas City, Missouri, 2005 
• PhD, Anatomy and Cell Biology, University of Iowa, Iowa City, 2000
• BS, Biology-Genetics (summa cum laude), St. Cloud State University, St. Cloud, Minnesota, 1995

POSTGRADUATE EDUCATION 

• HDR Brachytherapy Fellowship, American Brachytherapy Society, Tacoma, Washington, 2011
• Resident, Radiation Oncology, Fox Chase Cancer Center, Philadelphia, 2006-2010
• Internship, Transitional Year, Mercy Catholic Medical Center, Darby, Pennsylvania, 2005-2006

ACADEMIC APPOINTMENTS 

• Visiting Associate Professor, Radiation Oncology, University of Maryland College of Medicine, Baltimore, 2025 - present
• Adjunct Associate Professor, Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, 2024 - present
• Professor, Radiation Oncology, Penn State University College of Medicine, Hershey, Pennsylvania, 2018-2022
• Associate Professor, Radiation Oncology Penn State University College of Medicine, Hershey, Pennsylvania, 2015-2018
• Assistant Professor, Radiation Oncology, University of Maryland College of Medicine, Baltimore, 2010-2015    

HOSPITAL APPOINTMENTS

• Maryland Proton Treatment Center, Baltimore, 2025 - present
• Medical Director, Radiation Oncology, WellSpan Health, York, Pennsylvania, 2022 - present
• Associate Chair, Radiation Oncology, Penn State Hershey Medical Center/St. Joseph Cancer Center, Reading, Pennsylvania, 2015-2022
• Radiation Oncology, University of Maryland Medical System, Baltimore, 2010-2015

SERVICE TO ASTRO 

• Member, Finance Committee, 2024 - present
• Member, Community Engagement and Advocacy Committee, 2024 - present
• Member, Guidelines Subcommittee, 2021-2023
• Member, GI Resource Panel, 2020 - present
• Member, Code Utilization and Acquisition Committee, 2014-2022
• Member, Payer Relations Committee, 2013-2022
• Associate Editor, Annual Radiation and Cancer Biology Examination Guide, 2010-2014
• Member, Health Policy Council-Regulatory Subcommittee, 2009-2015
• Member, Emerging Technologies Committee- Evaluations Subcommittee, 2009-2011
• Member, Government Relations Committee, 2007-2008
• Member, Congressional Relations Subcommittee, 2006-2007

SERVICE TO OTHER ONCOLOGY OR RADIOLOGY ORGANIZATIONS 

• American Radium Society
  • Vice-chair, GI Appropriate Use Criteria Committee, 2022 - present
  • Member, GI Appropriate Use Criteria Committee, 2018 - present
  • Member, Radiation Oncology Program Committee, 2019 - present
• American Board of Radiology 
  • Initial Certifying Oral Examiner (GI), 2018 - present
  • Initial Certifying Oral Exam Question Writer (GI), 2016 - present
  • Maintenance of Certification Question Writer (GI), 2016-2017
• American College of Radiation Oncology
  • GI Disease Site Team Leader, Practice Accreditation Program 2012 - present
  • Planning Committee, 2020-2022
  • 90Y Microsphere Consensus Guidelines Leader, 2020-2022
• National Institutes of Health
  • Member, Rectal/Anal Task Force, 2011-2012
• Cancer and Leukemia Group B (CALGB)
  • Radiation Oncology Committee, Quality Subcommittee, 2010-2015

How would ASTRO’s Strategic Plan inspire you (your leadership) as an ASTRO Board Member?

I am running for the position of Secretary/Treasurer of ASTRO. In this position, I would be committed to supporting the missions of ASTRO, namely, advancing innovative research, educating our membership, contributing to the improvement of clinical cancer care, and advocating for our specialty and our patients on Capitol Hill.

My foremost responsibility in the role of Treasurer would be to ensure ASTRO’s financial strength and stability through thoughtful oversight of its endowment and judicious use of its resources. We have all experienced the vicissitudes of the market in recent days; prudent stewardship of our financial resources is more important than ever.

With a solid financial base, the ASTRO Board would be in a better position to execute its most vital responsibilities. To start with, the landscape of cancer care is changing more rapidly, and perhaps more profoundly, than ever in our history. The advent of immunotherapy and expansive catalogue of novel targeted agents and antibody-drug conjugates have transformed systemic therapy, both supplementing and replacing conventional chemotherapy. These advances have also changed how radiotherapy is used and added uncertainty as to the interaction of our treatment with new agents. ASTRO must be on the forefront of supporting our new understanding of how radiotherapy will complement new systemic therapies. As a community, we need a proactive stance on incorporating our treatment in evolving paradigms of cancer care.

The pace of research in cancer has been accelerating, adding new data at an extraordinary rate. The complexity of our work environment is increasing the demands of lifelong learning. ASTRO must rise to this challenge by redoubling its efforts to provide continuing education from site specific experts to the community of radiation oncologists at the speed of innovation.

A host of changes in radiotherapy, most notably the rise in moderate and ultra-hypofractionation, have yielded improvements in the therapeutic ratio, reduction in costs, and alleviation of the burden of care on our patients. This isn’t your grandfather’s radiotherapy! However, our current financial models discourage implementation of these advancements, disincentivizing the adoption of newer practicing and punishing the most forward thinking physicians. If we are to serve our patients as well as possible, ASTRO must lead the effort to update the structure of reimbursement and protect competitive RVU allocations. At the same time, we are seeing the employment landscape consolidate rapidly, with fewer (but larger) hospital systems absorbing independent practices and hospitals. Once formed, these systems are using their growing monopsony power to limit physician autonomy. ASTRO, working together with partner organizations such as the ACR and AMA, must help its members navigate this complex terrain and preserve our professional independence that is so vital to fulfilling our professional duties.

EDUCATION

• MD, University of Chicago, Pritzker School of Medicine; Chicago, 2004
• MBA, University of Chicago, Booth School of Business; Chicago, 2004
  • Concentrations in Economics and Entrepreneurship
  • Certificate in Health Administration and Policy
• BS, Psychology (Magna Cum Laude and with Honors), Brown University; Providence, Rhode Island, 1998

POSTGRADUATE EDUCATION

• Resident, Radiation Oncology, Rush University Medical Center, Chicago, 2005-2009
• Transitional Internship, Rush University Medical Center, Chicago, 2004-2005

ACADEMIC APPOINTMENTS

• Professor, Radiation Oncology and Medical Education, Northwestern University, 2024 – present
• Vice-Chair of Education, Radiation Oncology, Northwestern University, Chicago, 2019 – present
• Associate Professor, Medical Education, Northwestern University, Chicago, 2019-2024
• Associate Professor, Radiation Oncology, Northwestern University, Chicago, 2017-2024
• Program Director, Radiation Oncology, Northwestern University, Chicago, 2013-2020
• Assistant Professor, Radiation Oncology, Northwestern University, Chicago, 2009-2017

HOSPITAL APPOINTMENTS

• Radiation Oncology, Northwestern Memorial Hospital, Chicago, 2009 – present

SERVICE TO ASTRO

• Radiation Oncology Institute (ROI) Research Committee, 2018-2022
• Finance/Audit Committee of ASTRO, 2011-2016
• Payment Systems Committee of ASTRO, 2007-2011
• Chair, ARRO Executive Board, 2008-2009
• Events Officer, ARRO Executive Board, 2007-2008
• Representative to ACR, ARRO Executive Board, 2007-2009

SERVICE TO OTHER ONCOLOGY OR RADIOLOGY ORGANIZATIONS

• American College of Radiology (ACR)
  • Section Chair of Breast Cancer, In-Service Examination (TXIT), 2019 – Present
  • Test Writer, Breast Cancer Section, In-Service Examination (TXIT), 2017-2019
• Chicago Radiological Society (CRS)
  • President, 2016-2017
  • Secretary/Treasurer/President-Elect, 2015-2016
  • Secretary/Treasurer/Vice-President, 2014-2015
  • Trustee and Program Director, 2009-2014

BIOGRAPHICAL SKETCH

I am a radiation oncologist who treats breast and gynecologic cancers at Northwestern in Chicago. I have been involved in ASTRO, the ACR, and my local chapter – the Chicago Radiological Society – for almost 20 years. Most relevantly, because my background includes an MBA, I served on ASTRO’s Finance/Audit Committee and Payment Systems Committee.